Skip to main content
Erschienen in: Annals of Surgical Oncology 13/2019

19.09.2019 | Breast Oncology

Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women

verfasst von: Kara Vande Walle, MD, Dou-Yan Y. Yang, PhD, Trista J. Stankowski-Drengler, MD, Devon Livingston-Rosanoff, MD, PhD, Sara Fernandes-Taylor, PhD, Jessica R. Schumacher, PhD, Lee G. Wilke, MD, Caprice C. Greenberg, MD, MPH, Heather B. Neuman, MD, MS

Erschienen in: Annals of Surgical Oncology | Ausgabe 13/2019

Einloggen, um Zugang zu erhalten

Abstract

Background

Reduction mammaplasty is a common operation performed for healthy women. The estimated incidence of breast cancer diagnosed at the time of reduction mammaplasty varies from 0.06 to 4.5%, and information on the care of these patients is limited. This study aimed to determine the incidence of breast cancer identified incidentally during reduction mammaplasty and to characterize preoperative imaging.

Methods

Women 18 years of age or older who underwent reduction mammaplasty from 2013 to 2015 were identified from the Truven Health MarketScan® Research Databases. Patients with prior breast cancer were excluded. Descriptive statistics were calculated for patient characteristics, incidental breast cancer, preoperative breast imaging, and postoperative treatment.

Results

Reduction mammaplasty was performed for 18,969 women with a mean age of 42.5 years. Of these patients, 186 (0.98%) were incidentally found to have breast cancer, with 134 (0.71%) having invasive breast cancer and 52 (0.27%) having carcinoma in situ. The patients with incidentally found cancer were older than the patients without cancer (50.8 vs. 42.5 years; p < 0.001). Overall, 58.2% of the patients had undergone mammography before reduction mammoplasty. The rates were higher (> 80%) for the patients older than 40 years. Preoperative mammography was performed for 76.3% of those with a diagnosis of breast cancer at time of reduction mammoplasty.

Conclusions

Breast cancer diagnosed incidentally at the time of reduction mammaplasty is uncommon and often radiographically occult. The majority of women older than 50 years appropriately received preoperative mammography. These data can be used to manage patient expectations about the potential for the incidental diagnosis of breast cancer at reduction mammaplasty, even with a negative preoperative mammography.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Acevedo F, Armengol VD, Deng Z, et al. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2018;173: 201–7.CrossRef Acevedo F, Armengol VD, Deng Z, et al. Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions. Breast Cancer Res Treat. 2018;173: 201–7.CrossRef
3.
Zurück zum Zitat Bruhlmann Y, Tschopp H. Breast reduction improves symptoms of macromastia and has a long-lasting effect. Ann Plast Surg. 1998;41:240–5.CrossRef Bruhlmann Y, Tschopp H. Breast reduction improves symptoms of macromastia and has a long-lasting effect. Ann Plast Surg. 1998;41:240–5.CrossRef
4.
Zurück zum Zitat Ducic I, Iorio ML, Al-Attar A. Chronic headaches/migraines: extending indications for breast reduction. Plast Reconstr Surg. 2010;125:44–9.CrossRef Ducic I, Iorio ML, Al-Attar A. Chronic headaches/migraines: extending indications for breast reduction. Plast Reconstr Surg. 2010;125:44–9.CrossRef
5.
Zurück zum Zitat Perez-Panzano E, Gascon-Catalan A, Sousa-Dominguez R, Carrera-Lasfuentes P, Garcia-Campayo J, Guemes-Sanchez A. Reduction mammaplasty improves levels of anxiety, depression, and body image satisfaction in patients with symptomatic macromastia in the short and long term. J Psychosom Obstet Gynaecol. 2017;38:268–75.CrossRef Perez-Panzano E, Gascon-Catalan A, Sousa-Dominguez R, Carrera-Lasfuentes P, Garcia-Campayo J, Guemes-Sanchez A. Reduction mammaplasty improves levels of anxiety, depression, and body image satisfaction in patients with symptomatic macromastia in the short and long term. J Psychosom Obstet Gynaecol. 2017;38:268–75.CrossRef
6.
Zurück zum Zitat Blomqvist L, Eriksson A, Brandberg Y. Reduction mammaplasty provides long-term improvement in health status and quality of life. Plast Reconstr Surg. 2000;106:991–7.CrossRef Blomqvist L, Eriksson A, Brandberg Y. Reduction mammaplasty provides long-term improvement in health status and quality of life. Plast Reconstr Surg. 2000;106:991–7.CrossRef
7.
Zurück zum Zitat Uson Junior PLS, Callegaro Filho D, Bugano DDG, et al. Incidental findings in reduction mammoplasty specimens in patients with no prior history of breast cancer. An analysis of 783 specimens. Pathol Oncol Res. 2018;24:95–9.CrossRef Uson Junior PLS, Callegaro Filho D, Bugano DDG, et al. Incidental findings in reduction mammoplasty specimens in patients with no prior history of breast cancer. An analysis of 783 specimens. Pathol Oncol Res. 2018;24:95–9.CrossRef
8.
Zurück zum Zitat Tadler M, Vlastos G, Pelte MF, et al. Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients. Br J Cancer. 2014;110:788–91.CrossRef Tadler M, Vlastos G, Pelte MF, et al. Breast lesions in reduction mammaplasty specimens: a histopathological pattern in 534 patients. Br J Cancer. 2014;110:788–91.CrossRef
9.
Zurück zum Zitat Waldner M, Klein HJ, Kunzi W, Guggenheim M, Plock JA, Giovanoli P. Occurrence of occult malignancies in reduction mammoplasties. Front Surg. 2018;5:17.CrossRef Waldner M, Klein HJ, Kunzi W, Guggenheim M, Plock JA, Giovanoli P. Occurrence of occult malignancies in reduction mammoplasties. Front Surg. 2018;5:17.CrossRef
10.
Zurück zum Zitat Merkkola-von Schantz P, Jahkola T, Carpelan A, Krogerus L, Hukkinen K, Kauhanen S. Adverse histopathology and imaging findings in reduction mammaplasty day-surgery patients. Scand J Surg. 2014;103:209–14.CrossRef Merkkola-von Schantz P, Jahkola T, Carpelan A, Krogerus L, Hukkinen K, Kauhanen S. Adverse histopathology and imaging findings in reduction mammaplasty day-surgery patients. Scand J Surg. 2014;103:209–14.CrossRef
11.
Zurück zum Zitat Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009;124:1386–92.CrossRef Ambaye AB, MacLennan SE, Goodwin AJ, Suppan T, Naud S, Weaver DL. Carcinoma and atypical hyperplasia in reduction mammaplasty: increased sampling leads to increased detection. A prospective study. Plast Reconstr Surg. 2009;124:1386–92.CrossRef
12.
Zurück zum Zitat Boice JD Jr, Friis S, McLaughlin JK, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control. 1997;8:253–8.CrossRef Boice JD Jr, Friis S, McLaughlin JK, et al. Cancer following breast reduction surgery in Denmark. Cancer Causes Control. 1997;8:253–8.CrossRef
13.
Zurück zum Zitat Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286–9.CrossRef Cook IS, Fuller CE. Does histopathological examination of breast reduction specimens affect patient management and clinical follow up? J Clin Pathol. 2004;57:286–9.CrossRef
14.
Zurück zum Zitat Desouki MM, Li Z, Hameed O, Fadare O, Zhao C. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health centers. Hum Pathol. 2013;44:1877–81.CrossRef Desouki MM, Li Z, Hameed O, Fadare O, Zhao C. Incidental atypical proliferative lesions in reduction mammoplasty specimens: analysis of 2498 cases from 2 tertiary women’s health centers. Hum Pathol. 2013;44:1877–81.CrossRef
15.
Zurück zum Zitat Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg. 1999;103:1682–6.CrossRef Tang CL, Brown MH, Levine R, Sloan M, Chong N, Holowaty E. Breast cancer found at the time of breast reduction. Plast Reconstr Surg. 1999;103:1682–6.CrossRef
16.
Zurück zum Zitat Greco R, Noone B. Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg. 2017;139:230e–9e.CrossRef Greco R, Noone B. Evidence-based medicine: reduction mammaplasty. Plast Reconstr Surg. 2017;139:230e–9e.CrossRef
17.
Zurück zum Zitat Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599–614.CrossRef Oeffinger KC, Fontham ET, Etzioni R, et al. Breast cancer screening for women at average risk: 2015 guideline update from the American Cancer Society. JAMA. 2015;314:1599–614.CrossRef
19.
Zurück zum Zitat Keleher AJ, Langstein HN, Ames FC, et al. Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J. 2003;9:120–5.CrossRef Keleher AJ, Langstein HN, Ames FC, et al. Breast cancer in reduction mammaplasty specimens: case reports and guidelines. Breast J. 2003;9:120–5.CrossRef
20.
Zurück zum Zitat Butler CE, Hunt KK, Singletary SE. Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003;50:193–7.CrossRef Butler CE, Hunt KK, Singletary SE. Management of breast carcinoma identified intraoperatively during reduction mammaplasty. Ann Plast Surg. 2003;50:193–7.CrossRef
21.
Zurück zum Zitat Brown FE, Sargent SK, Cohen SR, Morain WD. Mammographic changes following reduction mammaplasty. Plast Reconstr Surg. 1987;80:691–8.CrossRef Brown FE, Sargent SK, Cohen SR, Morain WD. Mammographic changes following reduction mammaplasty. Plast Reconstr Surg. 1987;80:691–8.CrossRef
22.
Zurück zum Zitat Danikas D, Theodorou SJV, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesth Plast Surg. 2001;25:283–5.CrossRef Danikas D, Theodorou SJV, Kokkalis G, Vasiou K, Kyriakopoulou K. Mammographic findings following reduction mammoplasty. Aesth Plast Surg. 2001;25:283–5.CrossRef
23.
Zurück zum Zitat Slezak S, Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy. Plast Reconstr Surg. 2011;127:525–30.CrossRef Slezak S, Bluebond-Langner R. Occult carcinoma in 866 reduction mammaplasties: preserving the choice of lumpectomy. Plast Reconstr Surg. 2011;127:525–30.CrossRef
24.
Zurück zum Zitat Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006;72:397–400.PubMed Golshan M, Lesnikoski BA, Lester S. Sentinel lymph node biopsy for occult breast cancer detected during breast reduction surgery. Am Surg. 2006;72:397–400.PubMed
25.
Zurück zum Zitat Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124:1033–9.CrossRef Clark CJ, Whang S, Paige KT. Incidence of precancerous lesions in breast reduction tissue: a pathologic review of 562 consecutive patients. Plast Reconstr Surg. 2009;124:1033–9.CrossRef
26.
Zurück zum Zitat Young ZT, Close M, Herrera FA. National surgical quality improvement program analysis of 9110 reduction mammaplasty patients: identifying risk factors associated with complications in patients older than 60 years. Ann Plast Surg. 2019;82(6S Suppl 5):S446–9.CrossRef Young ZT, Close M, Herrera FA. National surgical quality improvement program analysis of 9110 reduction mammaplasty patients: identifying risk factors associated with complications in patients older than 60 years. Ann Plast Surg. 2019;82(6S Suppl 5):S446–9.CrossRef
27.
Zurück zum Zitat Winter R, Haug I, Lebo P, et al. Standardizing the complication rate after breast reduction using the Clavien-Dindo classification. Surgery. 2017;161:1430–5.CrossRef Winter R, Haug I, Lebo P, et al. Standardizing the complication rate after breast reduction using the Clavien-Dindo classification. Surgery. 2017;161:1430–5.CrossRef
Metadaten
Titel
Breast Cancer Found Incidentally After Reduction Mammaplasty in Young Insured Women
verfasst von
Kara Vande Walle, MD
Dou-Yan Y. Yang, PhD
Trista J. Stankowski-Drengler, MD
Devon Livingston-Rosanoff, MD, PhD
Sara Fernandes-Taylor, PhD
Jessica R. Schumacher, PhD
Lee G. Wilke, MD
Caprice C. Greenberg, MD, MPH
Heather B. Neuman, MD, MS
Publikationsdatum
19.09.2019
Verlag
Springer International Publishing
Erschienen in
Annals of Surgical Oncology / Ausgabe 13/2019
Print ISSN: 1068-9265
Elektronische ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-019-07726-9

Weitere Artikel der Ausgabe 13/2019

Annals of Surgical Oncology 13/2019 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

CME: 2 Punkte

Prof. Dr. med. Gregor Antoniadis Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

CME: 2 Punkte

Dr. med. Benjamin Meyknecht, PD Dr. med. Oliver Pieske Das Webinar S2e-Leitlinie „Distale Radiusfraktur“ beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

CME: 2 Punkte

Dr. med. Mihailo Andric
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.